miR-320a通过向RAD51并通过GPX4调节铁亡来增强非小细胞肺癌中的放射敏感性
Jinyan Lv1,2, Chuanhao Zhang1,2,3, Xinyao Ren1
1Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China.
Scientific reports
|March 1, 2026
概括
微RNA-320a通过向ferroptosis的关键调节者RAD51来增强非小细胞肺癌 (NSCLC) 的辐射敏感性. 这一发现为改善NSCLC放射治疗结果提供了一条新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 放射治疗对于非小细胞肺癌 (NSCLC) 治疗至关重要,但放射电阻限制了其有效性.
- 微RNAs,如miR-320a,影响NSCLC辐射敏感性的精确分子机制仍然不完全理解.
研究的目的:
- 研究miR-320a在NSCLC中调节辐射敏感性的作用.
- 阐明涉及miR-320a向RAD51的分子机制及其对铁亡和放射治疗反应的影响.
主要方法:
- 使用TCGA数据和qRT-PCR分析NSCLC组织和细胞系中miR-320a表达的分析.
- 生物信息预测和双露西法酶记者分析验证RAD51作为miR-320a目标.
- 功能性测试评估了miR-320a和RAD51操纵对NSCLC细胞辐射敏感性,增殖,殖民地形成,迁移和铁亡标志物 (脂质ROS,GPX4) 的影响.
主要成果:
- 在NSCLC中,miR-320a的表达显著降低,并且与临床放射敏感性正相关.
- 过度表达miR-320a增加了NSCLC的辐射敏感性,而RAD51被证实是直接的目标,与miR-320a相反相关,辐射敏感性降低.
- miR-320a/RAD51轴通过GPX4调节铁;miR-320a恢复或RAD51抑制增加了脂质过氧化和对放射治疗敏感的细胞.
结论:
- miR-320a通过直接降低RAD51表达的调节来增强NSCLC的辐射敏感性.
- 该miR-320a/RAD51/GPX4通路是NSCLC辐射敏感性和铁亡的关键决定因素.
- 针对这一轴,为克服NSCLC中的放射电阻提供了一个有希望的战略.
相关概念视频
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K


